EPA:SAN - Euronext Paris - Matif - FR0000120578 - Common Stock - Currency: EUR
Overall SAN gets a fundamental rating of 5 out of 10. We evaluated SAN against 50 industry peers in the Pharmaceuticals industry. SAN has an average financial health and profitability rating. SAN has a decent growth rate and is not valued too expensively. Finally SAN also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.77% | ||
ROE | 13.83% | ||
ROIC | 13.31% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 23.19% | ||
PM (TTM) | 14.84% | ||
GM | 70.78% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.18 | ||
Debt/FCF | 2.72 | ||
Altman-Z | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.37 | ||
Quick Ratio | 0.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.69 | ||
Fwd PE | 9.01 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 25.86 | ||
EV/EBITDA | 10.91 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 4.76% |
EPA:SAN (6/30/2025, 7:00:00 PM)
82.21
-0.28 (-0.34%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 4.76% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.69 | ||
Fwd PE | 9.01 | ||
P/S | 2.9 | ||
P/FCF | 25.86 | ||
P/OCF | 18.3 | ||
P/B | 2.7 | ||
P/tB | 19.49 | ||
EV/EBITDA | 10.91 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.77% | ||
ROE | 13.83% | ||
ROCE | 16.06% | ||
ROIC | 13.31% | ||
ROICexc | 14.47% | ||
ROICexgc | 47.61% | ||
OM | 23.19% | ||
PM (TTM) | 14.84% | ||
GM | 70.78% | ||
FCFM | 11.2% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.18 | ||
Debt/FCF | 2.72 | ||
Debt/EBITDA | 0.68 | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | 250 | ||
Cash Conversion | 55.78% | ||
Profit Quality | 75.5% | ||
Current Ratio | 1.37 | ||
Quick Ratio | 0.69 | ||
Altman-Z | N/A |